$ICDIQ
Independence Contract Drilling, Inc.

2023 Q1 Form 10-K Financial Statement

#000153702823000015 Filed on March 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $63.76M $60.26M $186.7M
YoY Change 82.21% 110.98% 112.28%
Cost Of Revenue $37.46M $35.95M $123.4M
YoY Change 37.9% 49.5% 62.9%
Gross Profit $26.30M $24.31M $63.31M
YoY Change 236.01% 438.5% 418.77%
Gross Profit Margin 41.24% 40.34% 33.91%
Selling, General & Admin $6.727M $7.713M $24.81M
YoY Change 28.67% 99.3% 58.03%
% of Gross Profit 25.58% 31.73% 39.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.85M $10.72M $40.40M
YoY Change 11.31% 10.89% 3.86%
% of Gross Profit 41.28% 44.12% 63.81%
Operating Expenses $6.727M $18.44M $24.81M
YoY Change 28.67% 34.67% 58.03%
Operating Profit $8.729M $5.871M -$2.095M
YoY Change -231.52% -163.98% -95.14%
Interest Expense -$8.719M -$8.570M -$29.58M
YoY Change 86.5% 119.8% 94.66%
% of Operating Profit -99.89% -145.97%
Other Income/Expense, Net
YoY Change
Pretax Income $10.00K -$3.518M -$71.52M
YoY Change -100.02% -73.02% 48.44%
Income Tax -$2.000K -$6.979M -$6.196M
% Of Pretax Income -20.0%
Net Earnings $12.00K $3.461M -$65.32M
YoY Change -100.02% -110.99% -2.09%
Net Earnings / Revenue 0.02% 5.74% -34.99%
Basic Earnings Per Share $0.00 -$5.01
Diluted Earnings Per Share $0.00 $0.25 -$5.01
COMMON SHARES
Basic Shares Outstanding 13.64M 13.62M 13.03M
Diluted Shares Outstanding 13.88M 13.03M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.715M $5.326M $5.326M
YoY Change -28.12% 28.65% 28.65%
Cash & Equivalents $6.715M $5.326M $5.326M
Short-Term Investments
Other Short-Term Assets $1.000K $1.000K $5.061M
YoY Change -88.89% -88.89% 5.72%
Inventory $1.543M $1.508M $1.508M
Prepaid Expenses
Receivables $41.84M $39.78M $39.78M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $53.97M $51.67M $51.67M
YoY Change 36.89% 59.92% 59.92%
LONG-TERM ASSETS
Property, Plant & Equipment $380.1M $377.1M $377.1M
YoY Change 5.58% 3.65% 3.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.389M $1.960M $984.0K
YoY Change 8.54% -19.97% -2.77%
Total Long-Term Assets $381.1M $378.0M $378.0M
YoY Change 5.58% 3.63% 3.63%
TOTAL ASSETS
Total Short-Term Assets $53.97M $51.67M $51.67M
Total Long-Term Assets $381.1M $378.0M $378.0M
Total Assets $435.1M $429.7M $429.7M
YoY Change 8.66% 8.21% 8.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.95M $31.95M $31.95M
YoY Change 43.15% 108.74% 108.74%
Accrued Expenses $13.55M $17.61M $11.38M
YoY Change 28.49% 56.59% -3.66%
Deferred Revenue $1.368M $1.003M
YoY Change -19.58% 85.06%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.071M $2.485M $2.485M
YoY Change -46.92% -44.33%
Total Short-Term Liabilities $42.57M $52.04M $52.04M
YoY Change 27.94% 35.92% 35.92%
LONG-TERM LIABILITIES
Long-Term Debt $163.9M $143.2M $143.2M
YoY Change 36.47% 1.05% 1.05%
Other Long-Term Liabilities $652.0K $7.474M $7.474M
YoY Change -65.58% 165.88% 165.88%
Total Long-Term Liabilities $652.0K $7.474M $150.7M
YoY Change -65.58% 165.88% 4.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.57M $52.04M $52.04M
Total Long-Term Liabilities $652.0K $7.474M $150.7M
Total Liabilities $219.4M $215.0M $215.0M
YoY Change -12.66% 6.5% 6.5%
SHAREHOLDERS EQUITY
Retained Earnings -$399.1M -$399.1M
YoY Change 1.66% 19.57%
Common Stock $618.7M $617.7M
YoY Change 13.37% 15.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $215.7M $214.7M $214.7M
YoY Change
Total Liabilities & Shareholders Equity $435.1M $429.7M $429.7M
YoY Change 8.66% 8.21% 8.21%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $12.00K $3.461M -$65.32M
YoY Change -100.02% -110.99% -2.09%
Depreciation, Depletion And Amortization $10.85M $10.72M $40.40M
YoY Change 11.31% 10.89% 3.86%
Cash From Operating Activities $13.56M $14.38M $28.58M
YoY Change -916.26% -866.52% -398.33%
INVESTING ACTIVITIES
Capital Expenditures $18.84M $20.76M $43.05M
YoY Change 199.97% -408.81% 162.24%
Acquisitions
YoY Change
Other Investing Activities $748.0K $1.994M $4.743M
YoY Change 26.99% 960.64% 132.84%
Cash From Investing Activities -$18.09M -$18.77M -$38.30M
YoY Change 217.87% 187.18% 166.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.918M 2.147M 10.91M
YoY Change -52.86% -73.97% -31.01%
NET CHANGE
Cash From Operating Activities 13.56M 14.38M 28.58M
Cash From Investing Activities -18.09M -18.77M -38.30M
Cash From Financing Activities 5.918M 2.147M 10.91M
Net Change In Cash 1.389M -2.240M 1.186M
YoY Change -73.3% 1282.72% -114.57%
FREE CASH FLOW
Cash From Operating Activities $13.56M $14.38M $28.58M
Capital Expenditures $18.84M $20.76M $43.05M
Free Cash Flow -$5.277M -$6.381M -$14.47M
YoY Change -33.54% -231.65% -44.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
136000
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77070
CY2022 dei City Area Code
CityAreaCode
281
CY2022 dei Local Phone Number
LocalPhoneNumber
598-1230
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001537028
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#AssetImpairmentCharges
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36590
CY2022 dei Entity Registrant Name
EntityRegistrantName
INDEPENDENCE CONTRACT DRILLING, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1653648
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
20475 State Highway 249
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10287931
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13613759
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Trading Symbol
TradingSymbol
ICD
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022Q2 dei Entity Public Float
EntityPublicFloat
27149805
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13641228
CY2022 dei Auditor Firm
AuditorFirmId
243
CY2022 dei Auditor Name
AuditorName
BDO USA, LLP
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5326000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4140000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39775000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22211000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1508000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1171000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
325000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4736000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4787000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
51670000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
32309000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
376084000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
362346000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1960000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2449000
CY2022Q4 us-gaap Assets
Assets
429714000
CY2021Q4 us-gaap Assets
Assets
397104000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2485000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4464000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31946000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15304000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17608000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15617000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2902000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52039000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
38287000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
143223000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
141740000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12266000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
19037000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7474000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2811000
CY2022Q4 us-gaap Liabilities
Liabilities
215002000
CY2021Q4 us-gaap Liabilities
Liabilities
201875000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13698851
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
102000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10206085
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
617606000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
532826000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399097000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-333776000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
85092
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
81846
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3933000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3923000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
214712000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
195229000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
429714000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
397104000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186710000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87955000
CY2022 us-gaap Direct Operating Costs
DirectOperatingCosts
123399000
CY2021 us-gaap Direct Operating Costs
DirectOperatingCosts
75751000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24809000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15699000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40443000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
38915000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
350000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
196000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
245000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-150000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
188805000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
131070000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2095000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-43115000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-29575000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15193000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46347000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10128000
CY2022 icd Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
4265000
CY2022 icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10765000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-71517000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48180000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6196000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18532000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-65321000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-66712000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.89
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.89
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13026000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7507000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
247033000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-14000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8969000
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4239000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1724000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-66712000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
195229000
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-9000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3038000
CY2022 icd Stock Issued During Period Value Restructuring
StockIssuedDuringPeriodValueRestructuring
9163000
CY2022 icd Adjustments To Additional Paid In Capital Extinguishment Of Derivative
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivative
69232000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3390000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-65321000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
214712000
CY2022 us-gaap Profit Loss
ProfitLoss
-65321000
CY2021 us-gaap Profit Loss
ProfitLoss
-66712000
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
40443000
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
38915000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
350000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4644000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2295000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
196000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
245000
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
15859000
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
5883000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46347000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10128000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
346000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1115000
CY2022 icd Amortization Of Convertible Notes Issuance Costs And Debt Discount
AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount
6714000
CY2022 icd Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
4265000
CY2022 icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10765000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6771000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18532000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
256000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-52000
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
17820000
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12136000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
365000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
133000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-266000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-57000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10325000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12230000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28577000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9579000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43047000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2037000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16415000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4552000
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
0
CY2022 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
191000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38304000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14378000
CY2022 icd Payments Of Merger Consideration
PaymentsOfMergerConsideration
2902000
CY2022 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
10000
CY2021 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
10000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5811000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3594000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10913000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15818000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1186000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8139000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4140000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12279000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5326000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4140000
CY2022Q1 icd Market Price Of Oil
MarketPriceOfOil
123.64
CY2023Q1 icd Market Price Of Oil
MarketPriceOfOil
76.28
CY2022Q3 icd Natural Gas Price
NaturalGasPrice
9.85
CY2022Q4 icd Natural Gas Price
NaturalGasPrice
3.52
CY2023Q1 icd Natural Gas Price
NaturalGasPrice
2.12
CY2022Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
4300000
CY2022Q2 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
69200000
CY2022Q2 icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10800000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
300000
CY2021Q4 icd Sale Of Stock Maximum Aggregate Offering Price Additional Value
SaleOfStockMaximumAggregateOfferingPriceAdditionalValue
5900000
CY2022Q2 icd Sale Of Stock Maximum Aggregate Offering Price Additional Value
SaleOfStockMaximumAggregateOfferingPriceAdditionalValue
6500000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
0
CY2022Q4 icd Number Of Field Locations
NumberOfFieldLocations
6
CY2022Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
4300000
CY2022Q2 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
69200000
CY2022Q2 icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10800000
CY2022Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y8M12D
CY2021Q4 icd Fair Value Assets Level Transfers Amount
FairValueAssetsLevelTransfersAmount
0
CY2022Q4 icd Fair Value Assets Level Transfers Amount
FairValueAssetsLevelTransfersAmount
0
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the balance sheet date, and the reported amounts of revenues and expenses recognized during the reporting period. Actual results could differ from these estimates. Significant estimates made by management include depreciation of property, plant and equipment, impairment of property, plant and equipment and assets held for sale, and the collectability of accounts receivable.</p>
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186710000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87955000
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
39732000
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
22167000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1158000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
542000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
542000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
119000
CY2022 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
1158000
CY2021 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
542000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1158000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1158000
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
300000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
600000
CY2022 icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
3300000
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
3600000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
747000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
928000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5697000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3033000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
577000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
431000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1682000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1158000
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
387000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
585000
CY2022 icd Finance Lease Cost
FinanceLeaseCost
2069000
CY2021 icd Finance Lease Cost
FinanceLeaseCost
1743000
CY2022 us-gaap Lease Cost
LeaseCost
9090000
CY2021 us-gaap Lease Cost
LeaseCost
6135000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
732000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
964000
CY2022 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
373000
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
580000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5811000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3594000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
153000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4440000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1503000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
976000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1036000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1437000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
751000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
693000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
373000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4084000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
882000
CY2022 icd Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount
873000
CY2021 icd Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount
490000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1247000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1124000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1729000
CY2022Q4 icd Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
7307000
CY2021Q4 icd Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
14989000
CY2022Q4 icd Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
1994000
CY2021Q4 icd Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
1989000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5313000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
13000000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2485000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4464000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1599000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1305000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4084000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5769000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1086
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1084
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0812
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0864
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
833000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2743000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
390000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1110000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
549000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1223000
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
4402000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
99000
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
318000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1124000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
613000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
292000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1508000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1171000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
629888000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
580427000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
253804000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
218081000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
376084000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
362346000
CY2022 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
23300000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
228000
CY2021 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
13400000
CY2022 us-gaap Depreciation
Depreciation
40400000
CY2021 us-gaap Depreciation
Depreciation
38900000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3796000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3463000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
656000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
575000
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
283000
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
618000
CY2021Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
122000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4736000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4787000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6908000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4154000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3002000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2523000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1003000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
542000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3621000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2594000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
101000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4372000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
751000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
693000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2222000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
739000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17608000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15617000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
119000
CY2021Q4 icd Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
3281000
CY2022Q4 icd Deferred Tax Asset Right Of Use Asset
DeferredTaxAssetRightOfUseAsset
255000
CY2021Q4 icd Deferred Tax Asset Right Of Use Asset
DeferredTaxAssetRightOfUseAsset
379000
CY2022 us-gaap Interest Paid
InterestPaid
5084000
CY2021 us-gaap Interest Paid
InterestPaid
6918000
CY2022 icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
11686000
CY2021 icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
3564000
CY2022 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
4440000
CY2021 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1503000
CY2022 icd Transfer Of Assets From Held And Used To Held For Sale
TransferOfAssetsFromHeldAndUsedToHeldForSale
325000
CY2021 icd Transfer Of Assets From Held And Used To Held For Sale
TransferOfAssetsFromHeldAndUsedToHeldForSale
1082000
CY2022 icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
281000
CY2021 icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
65000
CY2021 icd Gain Loss On Extinguishment Of Debt Excluding Interest
GainLossOnExtinguishmentOfDebtExcludingInterest
10000000
CY2022 icd Initial Embedded Derivative Liability Upon Issuance Of Convertible Notes
InitialEmbeddedDerivativeLiabilityUponIssuanceOfConvertibleNotes
75733000
CY2022 icd Extinguishment Of Embedded Derivative Liability
ExtinguishmentOfEmbeddedDerivativeLiability
69232000
CY2022 icd Non Cash Or Part Non Cash Expenses Restructuring Fees
NonCashOrPartNonCashExpensesRestructuringFees
9163000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4084000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5769000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
186061000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
147952000
CY2022Q4 icd Convertible Notes Issuance Costs And Debt Discount
ConvertibleNotesIssuanceCostsAndDebtDiscount
40353000
CY2021Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1748000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2485000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4464000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
143223000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
141740000
CY2022Q4 icd Deferred Tax Asset Debt Instruments
DeferredTaxAssetDebtInstruments
2026000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1200000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
29268000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 icd Income Tax Reconciliation Derivatives
IncomeTaxReconciliationDerivatives
7629000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-15019000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10128000
CY2022Q4 icd Long Term Debt Gross Maturity Year Three
LongTermDebtGrossMaturityYearThree
11811000
CY2022Q4 icd Long Term Debt Gross Maturity Year Four
LongTermDebtGrossMaturityYearFour
170166000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
181977000
CY2022Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
4300000
CY2022Q2 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
69200000
CY2022Q2 icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10800000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
575000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
575000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-7480000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
17417000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
709000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1115000
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-6771000
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
18532000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6196000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18532000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
147000
CY2021 icd Effective Income Tax Rate Reconciliation Loan Forgiveness
EffectiveIncomeTaxRateReconciliationLoanForgiveness
-2127000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6196000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18532000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1518000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.087
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.385
CY2022Q4 icd Deferred Tax Assets Merger Related Expenses
DeferredTaxAssetsMergerRelatedExpenses
894000
CY2021Q4 icd Deferred Tax Assets Merger Related Expenses
DeferredTaxAssetsMergerRelatedExpenses
960000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1349000
CY2022Q4 icd Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
8024000
CY2022Q3 icd Number Of Directors
NumberOfDirectors
7
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
109531000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
96142000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
93733000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
100011000
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
845000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
740000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
41937000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
38000000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
222000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
315000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
43004000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
39055000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
78793000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
79993000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
12266000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
19037000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
444500000
CY2022Q4 icd Operating Loss Carryforwards Subject To Expiration
OperatingLossCarryforwardsSubjectToExpiration
134100000
CY2022Q4 icd Operating Loss Carryforwards Not Subject To Expiration
OperatingLossCarryforwardsNotSubjectToExpiration
310400000
CY2022 icd Operating Loss Carryforwards Expiration Amount
OperatingLossCarryforwardsExpirationAmount
94800000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4644000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2295000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27867
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
254.80
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
27867
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
254.80
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
85092
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-65321000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-66712000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.89
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13026000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7507000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13026000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7507000
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
7600000
CY2022 us-gaap Payments For Deposits
PaymentsForDeposits
900000
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
14000.0
CY2022Q4 icd Employment Agreement Number Of Employees
EmploymentAgreementNumberOfEmployees
6
CY2022 icd Employment Agreement Term
EmploymentAgreementTerm
P3Y
CY2022Q4 icd Employment Agreement Minimum Annual Cash Compensation
EmploymentAgreementMinimumAnnualCashCompensation
1900000
CY2022Q4 icd Employment Agreement Severance Clause Amount
EmploymentAgreementSeveranceClauseAmount
4900000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5000000.0
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78900000
CY2022Q1 icd Investor S Rights Agreement Number Of Directors Who Can Be Nominated
InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated
1
CY2022Q1 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
25000000.0
CY2022Q1 icd Investor S Rights Agreement Number Of Directors Who Can Be Nominated
InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated
1
CY2022Q1 icd Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director
NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector
2
CY2022Q1 icd Number Of Additional Representative To Be Appointed As Individual Director
NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector
1
CY2022Q1 icd Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director
NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector
2
CY2022Q1 icd Number Of Directors
NumberOfDirectors
6

Files In Submission

Name View Source Status
icd-20221231_pre.xml Edgar Link unprocessable
icd-20221231_def.xml Edgar Link unprocessable
0001537028-23-000015-index-headers.html Edgar Link pending
0001537028-23-000015-index.html Edgar Link pending
0001537028-23-000015.txt Edgar Link pending
0001537028-23-000015-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icd-20221231.xsd Edgar Link pending
icd-20221231x10k.htm Edgar Link pending
icd-20221231xex23d1.htm Edgar Link pending
icd-20221231xex31d1.htm Edgar Link pending
icd-20221231xex31d2.htm Edgar Link pending
icd-20221231xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
icd-20221231_cal.xml Edgar Link unprocessable
icd-20221231_lab.xml Edgar Link unprocessable
icd-20221231x10k_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending